Prostate Cancer

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. January 1, 2025

Prostate-specific antigen testing in the United States during 2008-2022 in relation to the US preventive services task force recommendations. January 1, 2025

A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa). January 1, 2025

Grading the Evidence for Physical Activity and any Outcome in Cancer Survivors: an Umbrella Review of 740 Meta-analytic associations. January 1, 2025

Functional and Oncological Outcomes of Very Large Prostate Sizes Post Robotic Radical Prostatectomy: A Propensity Score-Matched Analysis. January 1, 2025

Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices. December 31, 2024

PSA testing in primary care: is it time to change our practice? December 31, 2024

Patterns of recurrence following radiation and ADT for pathologic lymph node positive prostate cancer: A multi-institutional study. December 31, 2024

The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey. December 31, 2024

Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis. December 31, 2024

Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) During Radical Prostatectomy: A Systematic Review and Meta-analysis. December 30, 2024

How many cores should be collected per region of interest in fusion targeted prostate biopsy? A retrospective single institution statistical simulation. December 30, 2024

The Impact of Cancer Status on Anxiety in Prostate Cancer Patients: A Network Analysis. December 30, 2024

Accelerated growth and local progression of radiorecurrent prostate cancer in an orthotopic bioluminescent mouse model. December 30, 2024

Utility of quantitative measurement of T2 using restriction spectrum imaging for detection of clinically significant prostate cancer. December 30, 2024

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer. December 30, 2024

Epigenetic remodeling and 3D chromatin reorganization governed by NKX2-1 drive neuroendocrine prostate cancer. December 30, 2024

Time to Refine Prostate Cancer Epidemiology: Defining New Endpoints for Effective Screening and Causal Epidemiological Studies. December 27, 2024

Prostate Brachytherapy With Cs-131: Long-term Results Compared With Published Stereotactic Body Radiotherapy Data. December 27, 2024

High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography. December 27, 2024

Page 1 of 1449